Evidence map›Paper›PMID 19936837›Full record

ArticleAnnals of surgical oncology2010

Continued Exploration of Bevacizumab in Breast Cancer.

Rita S Mehta, Min-Ying Su

Abstract readLetterComment
In one paragraph

Article in Annals of surgical oncology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Rita S MehtaDivision of Hematology/Oncology, Department of Medicine, and Chao Family Comprehensive Cancer Center, University of California Irvine Medical Center, Orange, CA, USA.
Min-Ying Su

Funding

Prediction of Neoadjuvant Chemo Pathological Response Using MRI MarkersR01CA127927 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI SU, MIN-YING L. · 2008 to 2017
$5.0M
NCI NIH HHS R01 CA127927
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiogenesis InhibitorsAntibodies, MonoclonalColonic NeoplasmsFemaleHumansAngiogenesis InhibitorsAntibodies, Monoclonal

Identifiers

PMID19936837
PMCPMC2816792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.